ArticleEuropean journal of epidemiology2014
Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?
Article in European journal of epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Managing the moral expansion of medicine.BMC medical ethics · 2022Article
- Plastic diagnostics: The remaking of disease and evidence in personalized medicine.Social science & medicine (1982) · 2022Article
- Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study.BMC endocrine disorders · 2021Article
- Risk prediction model of gestational diabetes mellitus based on nomogram in a Chinese population cohort study.Scientific reports · 2020Article
- Resetting priorities in precision medicine: the role of social prescribing.Journal of the Royal Society of Medicine · 2020Article
- The Limits of Empowerment: How to Reframe the Role of mHealth Tools in the Healthcare Ecosystem.Science and engineering ethics · 2020Article
- Contributions of the UK biobank high impact papers in the era of precision medicine.European journal of epidemiology · 2020Review
- Molecular and genomic sciences in health: apply the established rules of evidence.International journal of public health · 2016Article
- Mastering variation: variance components and personalised medicine.Statistics in medicine · 2016Article
- The commercialization of university-based research: Balancing risks and benefits.BMC medical ethics · 2015Review
- The Rotterdam Study: 2016 objectives and design update.European journal of epidemiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24729105What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.